Search bioRxiv⌕ Search

Biology subjects

Wischhof, L.

Publications and source records attributed to Wischhof, L..

4 recordsLinked to original sources

Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

Efficient clearance of extracellular protein aggregates by microglia is essential for maintaining brain homeostasis and limiting the accumulation of pathological proteins during neurodegeneration. However, how inflammatory activation affects the ability of microglia to internalize and degrade these aggregates remains incompletely understood. Here, we show that lipopolysaccharide (LPS)-induced inflammatory activation impairs the degradation of extracellularly-acquired -synuclein (-Syn) and Tau aggregates while largely preserving their uptake. Mechanistically, Toll-like receptor 4 (TLR4) activation induces translational reprogramming and increases intracellular proteostatic demand, while inhibition of protein synthesis restores -Syn degradation without preventing inflammatory Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-{kappa}B) activation. Despite largely preserved canonical autophagic flux, inflammatory stimulation is associated with reduced expression of lysosomal proteins, including cathepsin D, suggesting insufficient lysosomal adaptation to increased intracellular demand. Consistent with this model, pharmacological activation of transcription factor EB (TFEB) restores aggregate degradation, indicating that the impairment can be overcome by enhancing lysosomal function. Supporting its potential relevance to human disease, microglial -Syn deposits in brain tissue from patients with dementia with Lewy bodies show limited spatial association with cathepsin D-positive structures. Together, our findings identify a demand-driven lysosomal bottleneck through which inflammatory activation compromises aggregate degradation without substantially affecting uptake, highlighting lysosomal adaptation as a critical determinant of microglial aggregate clearance during neuroinflammation.

cell biology↗

Metabolic Crossroads: AMDHD2 Couples the Hexosamine Biosynthetic Pathway to Acetyl-CoA Homeostasis in Pluripotent Stem Cells

Pluripotent stem cells (SCs) rely on metabolic rewiring to regulate self-renewal and differentiation. The hexosamine biosynthetic pathway (HBP) integrates multiple metabolic inputs to produce uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), a central substrate for protein and lipid glycoconjugates. While UDP-GlcNAc levels influence pluripotency, the broader metabolic roles of the HBP in stem cell maintenance and differentiation remain largely unexplored. Using proteomic and metabolomic analyses, we uncovered extensive enzymatic remodelling of the HBP during early mouse embryonic stem cell (mESC) differentiation, including a significant decrease in N-acetylglucosamine-6-phosphate (GlcNAc6P) levels, despite stable UDP-GlcNAc levels. Isotope labelling experiments revealed that pluripotent stem cells maintain UDP-GlcNAc biosynthesis through a combination of glucose-driven de novo synthesis and the N-Acetylglucosamine (GlcNAc) salvage pathway, both of which are downregulated during differentiation. Functionally, we identified GlcNAc6P--a point of convergence of the de novo synthesis and the salvage pathways--as a pivotal metabolite of stem cell fate. Preventing GlcNAc6Ps deacetylation by deleting or depleting AMDHD2 impaired mESC differentiation. Mechanistically, we demonstrated that GlcNAc6P catabolism is essential for sustaining cytosolic acetate and in turn acetyl-CoA levels, which are critical for lipid synthesis and histone modifications required for pluripotency exit. These findings establish AMDHD2 as a key supplier of cellular acetate and reveal an essential metabolic link between HBP activity and acetyl-CoA homeostasis. By expanding the role of the HBP beyond UDP-GlcNAc production, this study reveals an unrecognised metabolic vulnerability that can be exploited to manipulate stem cell identity.

molecular biology↗

TMEM65-dependent Ca2+ extrusion safeguards mitochondrial homeostasis

The bidirectional transport of Ca2+ into and out of mitochondria is a conserved biological process controlling multiple events, including metabolism, signaling, and cell fate. In the presence of membrane potential driving mitochondrial Ca2+ accumulation, transient changes of [Ca2+]mt in response to cytosolic [Ca2+] variations are ensured by a molecular machinery for Ca2+ influx and efflux embedded in the inner mitochondrial membrane (IMM). While it is well established that influx relies on the Mitochondrial Calcium Uniporter (MCU), efflux was expected to be molecularly diversified, given the occurrence of functionally different exchange pathways with either Na+ or H+1. Accordingly, dedicated transporters ensure proper Ca2+ homeostasis and tightly regulated mitochondrial bioenergetics, but the process is not yet fully elucidated. We here demonstrate that TMEM65, a protein with an unknown biological function, is a fundamental component of the Ca2+ efflux machinery of mitochondria. As the MCU, TMEM65 has a broad tissue expression and localizes to the IMM. Its overexpression dramatically enhances Na+- and Li+-dependent mitochondrial Ca2+ extrusion, which is abrogated by the pharmacological inhibitor CGP-37157. Conversely, its downregulation chronically elevates resting mitochondrial Ca2+ levels and inhibits efficient Ca2+ efflux upon cellular activation, culminating in mitochondrial calcium overload and causing organelle dysfunction. Since TMEM65 has been associated with a severe human mitochondrial disease2, we deleted the TMEM65 homologues in Caenorhabditis elegans (CeTMEM65). While the two CeTMEM65 orthologs are dispensable for the survival at permissive growing conditions, their loss undermines embryonic developments when eggs are exposed to mild temperature-stress. In this regard, we find that CeTMEM65 (null) alleles cause necrotic lesions that are suppressed by inhibiting the mitochondrial calcium uniporter MCU-1. Overall, these results unambiguously assign a primary role in mitochondrial Ca2+ homeostasis to the orphan protein TMEM65. More importantly, our findings describe a novel molecular component that may be relevant in pathological settings in which excessive mitochondrial Ca2+ accumulation critically contribute to degenerative pathways.

biochemistry↗

Comparative profiling of N-respirasomes predicts aberrant mitochondrial bioenergetics at single-cell resolution

AO_SCPLOWBSTRACTC_SCPLOWMitochondria sustain the energy demand of the cell. The composition and functional state of the mitochondrial oxidative phosphorylation system are informative indicators of organelle homeostasis and bioenergetic capacity. Here we describe a highly sensitive and reproducible method for single-cell visualization and quantification of mitochondrial respiratory supercomplexes as a novel means of measuring mitochondrial respiratory chain integrity. We apply a proximity ligation assay (PLA) and perform comparative studies of mitochondrial CI, CIII and CIV-containing supercomplexes (or N-respirasomes) in fixed human and mouse brain tissues, tumorigenic cells, iPSCs and iPSC-derived NPCs and neurons. Our optimized approach enables a quantitative in-situ assessment of even subtle mitochondrial lesions associated with aberrant respiration. By combining quantitative proteomics with single cell imaging analysis, we also report the mechanistic contribution of the MICOS complex subunit CHCHD3 in regulating N-respirasomes. Overall, our PLA-based profiling of N-respirasomes establishes a sensitive and complementary technique for detecting cell-type specific mitochondrial perturbations in fixed materials.

cell biology↗